This procedure aims to reduce the tumor burden within the abdominal cavity. Diseased sections of the peritoneum — and in some cases, affected organs such as parts of the intestine — are surgically removed. Following this cytoreductive surgery, a heated chemotherapeutic solution is circulated within the abdominal cavity to destroy any remaining tumor cells that could not be surgically eliminated.
In situations where surgery or HIPEC is not feasible, PIPAC offers a less invasive alternative. A specially formulated chemotherapeutic agent is delivered into the abdominal cavity in aerosolized form under pressure, allowing deep tissue penetration. PIPAC can be a promising option, particularly for patients who are not eligible for major surgery due to their general health condition.
Our advanced systems enable targeted cancer cell destruction while preserving healthy tissue. The combination of chemotherapy and hyperthermia has proven effective in the treatment of bladder cancer. Our devices are user-friendly and offer precise temperature control for optimized outcomes.
Our experienced team provides expert support throughout the integration of these innovative procedures. We have successfully partnered with leading university hospitals and medical centers and are committed to long-term collaboration.
Together, we are shaping the future of oncology through innovation and precision.